Search
for
Sort by
Research 211–240 of 1000+
- Narrowband ultraviolet B phototherapy for alopecia areata
- Scalp Pruritus: Review of the Pathogenesis, Diagnosis, and Management
- Lichen planopilaris epidemiology: a retrospective study of 80 cases
- Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study
- Scalp Seborrheic Dermatitis: What We Know So Far
- Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: A retrospective review of 92 cases
- An unusual presentation of dermatomyositis: The type Wong variant revisited
- Natural Sources of Therapeutic Agents Used in Skin Conditions
- Granzyme B in Autoimmune Skin Disease
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Sarcoidosis: Are there differences in your skin of color patients?
- Alopecia Areata. Current situation and perspectives
- Linear lupus panniculitis of the scalp presenting as alopecia along Blaschko’s lines: A distinct variant of lupus panniculitis in East Asians?
- Shedding: How to manage a common cause of hair loss
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Madarosis
- Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Telogen Effluvium
- Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
- Promising alternative clinical uses of prostaglandin F2α analogs: Beyond the eyelashes
- Management of ‘refractory’ skin disease in patients with lupus erythematosus
- Adolescent hair loss
- Alopecia areata: A review
- Tufted hair folliculitis developing in a recalcitrant lesion of pemphigus vulgaris
- Lupus panniculitis clinically simulating alopecia areata
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess
- Primary Scarring Alopecias